Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_2
2
50%
Ph phase_4
1
25%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (25.0%)
Phase 22 (50.0%)
Phase 41 (25.0%)

Trials by Status

unknown250%
completed125%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
completedphase_2

S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma

NCT01359592
recruitingphase_1

Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL

NCT06760039
unknownphase_4

Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma

NCT03513601
unknownphase_2

GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma

NCT00896519

Clinical Trials (4)

Showing 4 of 4 trials
NCT01359592Phase 2

S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma

Completed
NCT06760039Phase 1

Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL

Recruiting
NCT03513601Phase 4

Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma

Unknown
NCT00896519Phase 2

GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma

Unknown

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4